cs1-01 impact of immunosuppression on viral hepatitis b and c论文.pdf

International Journal of Infectious Diseases (2009) 13 (Supplement 1), S3–S24
Concurrent Sessions
Concurrent Session 1 – Immunology and Virology of of liver transplant recipients do develop recurrent HCV infec-
Viral Hepatitis tion. Subsequently, progression of disease progression is more
rapid in these patients receiving immunosuppression than in im-
mune competent patients. Response to anti-HCV therapy is also
CS1-01 Impact of Immunosuppression on Viral Hepatitis B reduced in liver transplant recipients.
and C For other solid organ transplants, HBsAg-positive recipients face
a high rate of reactivation of HBV. While some believe that
W. Ray Kim *. Mayo Clinic College of Medicine, Rochester, MN,
HBV reactivation in these patients is not as detrimental as
USA
in liver transplant recipients, antiviral prophylaxis is usually
Competent immune function is an important determinant of the recommended. Since interferon-based anti-HCV